Real world study on treatments to prevent infection in patients receiving bendamustine based therapies.
Home / Resource Library / Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience